Unexplained weight loss (UWL), clinically defined as a loss of more than 5% of body weight within a 6-12 month period without a known cause, can be a diagnostic challenge for physicians. It is often a manifestation of underlying serious conditions, requiring a comprehensive and systematic approach for effective management.
A thorough history taking and physical examination is the cornerstone of the initial evaluation. It is crucial to identify any changes in appetite, dietary habits, psychiatric symptoms, or medications that may contribute to weight loss. The physical examination should focus on signs of malnutrition, wasting syndromes, and systemic diseases.
Basic laboratory tests, including complete blood count, comprehensive metabolic panel, thyroid function tests, and inflammatory markers, are recommended in the initial workup. If these tests are inconclusive, advanced diagnostic tools such as imaging studies, endoscopies, or biopsies may be necessary.
Once the underlying cause is identified, management should be condition-specific and patient-centered. In cases where no cause is found, symptomatic management with nutritional support and appetite stimulants can be beneficial. Regular follow-up is essential to monitor the patient's progress and adjust treatment plans accordingly.
Unexplained weight loss is a complex clinical problem that requires a comprehensive approach for effective evaluation and management. A systematic and methodical approach can help identify the underlying cause, enabling appropriate, timely interventions. It is essential to remember that despite exhaustive investigations, a cause may not always be found, and symptomatic management becomes crucial.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation